Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07439471 · ClinicalTrials.gov registry record

Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance

A clinical trial of Cigarette Smoking-Related Carcinoma, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT07439471 is a study of Cigarette Smoking-Related Carcinoma that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 40 participants, below the 465-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07439471, a study of Cigarette Smoking-Related Carcinoma, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This study evaluates histories among cannabis and tobacco co-users of their initiation, escalation, and maintenance of the co-use behavior.

Interventions

  • OTHER Non-Interventional Study

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-03-28
Est. Completion 2027-03

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT07439471

The ClinicalTrials.gov registry entry for NCT07439471 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 465-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (91% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.

NCT07439471 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07439471 about?

NCT07439471 is a clinical study titled "Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance". This study evaluates histories among cannabis and tobacco co-users of their initiation, escalation, and maintenance of the co-use behavior.

What is the current status of trial NCT07439471?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2026-03-28. Estimated completion is 2027-03.

What conditions does trial NCT07439471 study?

This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.

What interventions are being tested in trial NCT07439471?

The interventions under investigation include: Non-Interventional Study (OTHER).

Who is sponsoring clinical trial NCT07439471?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07439471 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.